“…Currently, various invasive and noninvasive imaging modalities, such as ultrasound, CT, MR imaging with/ without MR cholangiopancreatography (MRCP), endoscopic retrograde cholangiography, and endoscopic ultrasound, can be used to diagnose bile duct cancer (2,12). Among these modalities, contrast-en-hanced MR imaging combined with MRCP using stateof-the-art MR scanners, can facilitate viewing longitudinal cancer spread by simultaneously assessing bile ducts upstream and downstream and can permit assessment of the vessels and the depth of invasion (9,(13)(14)(15)(16)(17). Therefore, the purposes of this study are to retrospectively evaluate the imaging features of early bile duct carcinoma on unenhanced and contrast-enhanced MR images as well as on MR cholangiography , and to correlate them with the clinicopathologic findings.…”